[Federal Register Volume 62, Number 33 (Wednesday, February 19, 1997)]
[Notices]
[Pages 7459-7460]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-4006]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[INFO-97-04]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 639-7090.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance

[[Page 7460]]

of the functions of the agency, including whether the information shall 
have practical utility; (b) the accuracy of the agency's estimate of 
the burden of the proposed collection of information; (c) ways to 
enhance the quality, utility, and clarity of the information to be 
collected; and (d) ways to minimize the burden of the collection of 
information on respondents, including through the use of automated 
collection techniques for other forms of information technology. Send 
comments to Wilma Johnson, CDC Reports Clearance Officer, 1600 Clifton 
Road, MS-D24, Atlanta, GA 30333. Written comments should be received 
within 60 days of this notice.

Proposed Projects

    1. The Tri-State Mining District: Lead Exposure and Immunotoxic 
Effects Study--New--The proposed study evaluates associations between 
immune system dysfunction/damage and exposure to lead among children in 
the Tri-State Mining District. This district encompasses several 
contaminated areas including three Superfund sites: The Oronogo-Duenweg 
Mining Belt site in Jasper County, Missouri; the Cherokee County Site 
in Kansas; and the Tar Creek, Ottawa County Site in Oklahoma.
    The proposed study consists of two repeated in-person interviews 
and biological testing for blood lead and immune function among 
participants of the ongoing lead screening programs in the Tri-State 
Mining district. Approximately 50 children identified as having blood 
lead <10 micrograms per decilitre and 50 children with blood lead 
levels <5 micrograms per decilitre will constitute the study and 
comparison groups respectively. Blood specimens will be obtained to 
measure lead, complete blood count, EP, ZPP, antibody titers, and the 
CDC/ATSDR recommended immune panel. A second blood drawn a month later 
will examine intra-personal immune tests stability and will help 
evaluate the relationship between immune results and recent illness. 
Parents will be interviewed using a children's health questionnaire 
that solicits information on demographics, the medical history of each 
child and the occurrences of recent illness. Statistical analyses will 
compare health outcome measures (symptoms, illness, change in immune 
parameters) to blood lead levels. Other than their time, there will be 
no cost to the respondents. The length of clearance requested is 3 
years.

----------------------------------------------------------------------------------------------------------------
                                                                                          Average               
                                                               Number of    Number of     burden/       Total   
                         Respondents                          respondents   reponses/     response    burden (in
                                                                            respondent    (in hrs)      hrs.)   
----------------------------------------------------------------------------------------------------------------
Child Health Questionnaire..................................          100            2          0.5          100
                                                             ---------------------------------------------------
    Total...................................................  ...........  ...........  ...........          100
----------------------------------------------------------------------------------------------------------------

    Dated: February 12, 1997.
Wilma G. Johnson,
Acting Associate Director for Policy Planning and Evaluation, Centers 
for Disease Control and Prevention (CDC).
[FR Doc. 97-4006 Filed 2-18-97; 8:45 am]
BILLING CODE 4163-18-P